Our hypothesis is that the surface proteins interact with the phospholipids and participate in the regulation of surfactant homeostasis. The goals of this project are to characterize the normal forms assumed by the lipid and protein components of surfactant from secretion by type II cells to alveolar clearance, recycling and catabolism. Normal radiolabeled lipid and protein components of surfactant will be used to identify the forms taken in the airspace by which component in vivo. Parallel experiments will be used to study how the surfactant components move through the form conversions of surfactant in vitro. The importance to and effects of the surfactant protein components SP-A, SP-B, and SP-C on surfactant form conversions in vitro and surfactant function will be evaluated using transgenic mice that are deficient or have abnormal levels of expression of the surfactant proteins. Surfactant component clearance from the airspaces, and recycling and/or catabolism will be quantified using an analog of dipalmitoylphosphatidylcholine and surfactant proteins with residualizing carbohydrate adducts that are not catabolized. The relative importance of type II cells, Clara cells and macrophages to surfactant homeostasis will be quantified, and subcellular organelles important to surfactant component trafficking will be identified using confocal microscopy. Understanding normal surfactant homeostasis will permit new insights into lung dysfunction with injury.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
1P01HL061646-01A1
Application #
6191712
Study Section
Project Start
1999-08-10
Project End
2000-06-30
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Whitsett, Jeffrey A; Weaver, Timothy E (2015) Alveolar development and disease. Am J Respir Cell Mol Biol 53:1-7
Conkright, Juliana J; Apsley, Karen S; Martin, Emily P et al. (2010) Nedd4-2-mediated ubiquitination facilitates processing of surfactant protein-C. Am J Respir Cell Mol Biol 42:181-9
Xu, Yan; Zhang, Minlu; Wang, Yanhua et al. (2010) A systems approach to mapping transcriptional networks controlling surfactant homeostasis. BMC Genomics 11:451
Suzuki, Takuji; Sakagami, Takuro; Young, Lisa R et al. (2010) Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med 182:1292-304
Hardie, William D; Hagood, James S; Dave, Vrushank et al. (2010) Signaling pathways in the epithelial origins of pulmonary fibrosis. Cell Cycle 9:2769-76
Whitsett, Jeffrey A; Wert, Susan E; Weaver, Timothy E (2010) Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 61:105-19
Kramer, Elizabeth L; Mushaben, Elizabeth M; Pastura, Patricia A et al. (2009) Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice. Am J Respir Cell Mol Biol 41:415-25
Wang, Mei; Bridges, James P; Na, Cheng-Lun et al. (2009) Meckel-Gruber syndrome protein MKS3 is required for endoplasmic reticulum-associated degradation of surfactant protein C. J Biol Chem 284:33377-83
Hardie, William D; Glasser, Stephan W; Hagood, James S (2009) Emerging concepts in the pathogenesis of lung fibrosis. Am J Pathol 175:3-16
Korfhagen, Thomas R; Le Cras, Timothy D; Davidson, Cynthia R et al. (2009) Rapamycin prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 41:562-72

Showing the most recent 10 out of 91 publications